VIS-FLX

N/A

Report date: 2025/04/15 16:50:51

Base Information

Drug NameVIS-FLX
Drug Alias Namehemagglutinin inhibitor (Visterra)VIS-FLX
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins inhibitors
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVisterra Inc
China Registration ClassN/A

Develop Information

Active CompaniesVir Biotechnology IncVisterra Inc
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A